A detailed history of M&T Bank Corp transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 14,742 shares of TMDX stock, worth $1.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,742
Previous 14,742 -0.0%
Holding current value
$1.02 Million
Previous $2.31 Million -0.0%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$135.68 - $176.11 $28,492 - $36,983
-210 Reduced 1.4%
14,742 $2.31 Million
Q2 2024

Jul 31, 2024

SELL
$72.62 - $150.62 $44,951 - $93,233
-619 Reduced 3.98%
14,952 $2.25 Million
Q1 2024

May 07, 2024

BUY
$70.86 - $89.93 $241,420 - $306,391
3,407 Added 28.01%
15,571 $1.15 Million
Q4 2023

Feb 06, 2024

BUY
$36.74 - $81.08 $130,096 - $287,104
3,541 Added 41.06%
12,164 $960,000
Q3 2023

Nov 02, 2023

BUY
$53.47 - $96.07 $126,616 - $227,493
2,368 Added 37.86%
8,623 $472,000
Q2 2023

Aug 09, 2023

BUY
$66.23 - $88.73 $57,951 - $77,638
875 Added 16.26%
6,255 $525,000
Q1 2023

May 11, 2023

SELL
$53.63 - $82.33 $74,438 - $114,274
-1,388 Reduced 20.51%
5,380 $407,000
Q4 2022

Feb 13, 2023

BUY
$39.08 - $64.29 $49,084 - $80,748
1,256 Added 22.79%
6,768 $417,000
Q4 2022

Feb 13, 2023

SELL
$39.08 - $64.29 $116,692 - $191,969
-2,986 Reduced 35.14%
5,512 $340,000
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $268,196 - $473,763
8,498 New
8,498 $354,000
Q4 2021

Feb 07, 2022

SELL
$19.16 - $32.68 $592,044 - $1.01 Million
-30,900 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$25.92 - $34.51 $67,547 - $89,933
-2,606 Reduced 7.78%
30,900 $1.02 Million
Q2 2021

Aug 13, 2021

BUY
$21.63 - $40.07 $292,005 - $540,945
13,500 Added 67.48%
33,506 $1.11 Million
Q1 2021

May 06, 2021

BUY
$17.75 - $47.82 $355,106 - $956,686
20,006 New
20,006 $830,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.2B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.